Mondobiotech Holding AG Company presentation

More documents

Recommendations

Info

Current Patent Portfolio • 19 Granted Patents: EP 037 221 710, AU 2003236072, CN 03813424.1, HK 061002126 , NO 2004-0488 and in the US 7951778, AU 2006203749, AU 2002220729, EP 047 380 795, US 10/564,849, AU 2004255379 and CN 200480024479.7, EP 06707454.2, AU 2006222233, NZ 560648, IN 1363/MUMNP/2007 and in Mexico (number not notified yet), EP 218 792 5 and EP (number not notified yet). • 22 Patent Families under examination: in Europe, US, Japan, Canada and other countries • 5 written Intentions to Grant by the European Patent Office • 1 written Intention to Grant by the US Patent Office • 1 oral Intention to Grant by the European Patent Office 34
Orphan Drug Designations 10 Granted Orphan Drug Designations in US and EU 2003 EMEA: ODD for DK-1000 in PAH and CTEPH received 23/12/2003 (EU/3/03/173) 2005 FDA: ODD for DK-1000 in PAH received 22/02/2005 2005 EMEA: ODD for DK-1001 in IPF received 30/05/2005 (EU/3/05/281) 2005 FDA: ODD for DK-1000 in ARDS acquired 01/06/2005 2006 EMEA: ODD for DK-1000 in Acute Lung Injury (ALI) received 28/08/2006 (EU/3/06/395) 2007 EMEA: ODD for DK-1000 in Sarcoidosis received 14/09/2007(EU/3/07/473) 2010 FDA: ODD for DK-0210 in Chronic Beryllium Disease received 02/09/2010 2011 FDA: ODD for DK-0112 in Sarcoidosis received 04/02/2011 2011 FDA: ODD for DK-0014 in HBV induced Hepatocellular Carcinoma received 18/04/2011 2011 EMEA: ODD for DK-0141 in ALI/ARDS acquired in May 2011 35
Page 1 and 2: Mondobiotech Holding AG Company pre
Page 3 and 4: mondoBIOTECH at a glance • Headqu
Page 5 and 6: Board of Directors Robert Edward Pa
Page 7 and 8: Our approach to drug discovery •
Page 9 and 10: Introduction to the Search&Match me
Page 11 and 12: The Model • Knowledge from litera
Page 13 and 14: The Search and Match Software Platf
Page 15 and 16: Match • Any path through the know
Page 17 and 18: Match - a multi-technique approach
Page 19 and 20: Bio-Mathematical Technology Platfor
Page 21 and 22: Match - Project DK-0112-01 21
Page 23 and 24: Match - Project DK-1001-01 23
Page 25 and 26: MPC Validation: the mondoBIOTECH Co
Page 27 and 28: Set up of new projects PROJECT SET
Page 29 and 30: Intellectual Property Strategy & Cu
Page 31 and 32: mondoBIOTECH’s IP Strategy Two in
Page 33: mondoBIOTECH’s IP Strategy: Two I
Page 37 and 38: Why Peptides Peptides characteristi
Page 40 and 41: Diversifying the Risk in Drug Disco
Page 42 and 43: Current Pipeline DasKloster 1000-01
Page 46: Scientific Snapshot Information: DK
Page 49 and 50: Scientific Snapshot Information: DK
Page 51 and 52: Products licensed DasKloster 1001-0
Page 53 and 54: Licensed Products • Aviptadil pla
Page 55: mondoBIOTECH holding AG DasKloster

Mondobiotech Holding AG Company presentation

Create successful ePaper yourself

Delete template?

Save as template?